Basso Stephen 4

What Happened Stephen Basso, Chief Financial Officer of Innoviva, Inc. (INVA), was granted 37,994 restricted stock units (RSUs) and 93,750 derivative awards (non‑statutory stock options) on May 4, 2026. The Form 4 reports these awards at $0.00 (no cash paid by the reporting person). These are awards/compensation grants rather than open‑market purchases or sales.

Key Details

• Transaction date(s): May 4, 2026. Report filed: May 6, 2026 (timely filing).
• Reported amounts: 37,994 RSUs (grant A) and 93,750 derivative awards/options (grant A); price reported $0.00 for both.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote summary:
  • F1: Grants (RSUs and Options) were conditionally made subject to stockholder approval of Innoviva's 2026 Equity Incentive Plan (see the company’s Schedule 14A filed March 24, 2026).
  • F2: Vesting: 25% of each award vests on February 20, 2027, then the balance vests in 12 substantially equal quarterly installments thereafter (service‑based). Accelerated vesting may apply in certain change‑in‑control or involuntary termination scenarios, subject to release requirements.

Context These entries are compensation awards (RSUs and options) that typically vest over time and do not represent an immediate purchase or sale of stock. The 93,750 derivative line refers to option awards (not exercised or sold). Because the filing reports $0, no cash changed hands at grant; value to the executive depends on future vesting and, for options, any exercise price and share price at exercise. The filing appears to be timely (filed within the usual two‑business‑day window).